PRIMARY PERITONEAL CANCER
Clinical trials for PRIMARY PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Three-Drug attack on tough ovarian cancers
Disease control Not yet recruitingThis study is testing whether a combination of three drugs—benmelstobart, anlotinib, and cyclophosphamide—can help control recurrent ovarian, fallopian tube, or primary peritoneal cancer. It aims to see if this treatment can delay cancer progression and is safe for patients. The …
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New Two-Pronged immune drug joins fight against tough ovarian cancers
Disease control Not yet recruitingThis study is testing if adding a new immune-boosting drug (Aitua) to standard chemotherapy helps patients with advanced ovarian cancer. The goal is to shrink tumors better before surgery, allowing surgeons to remove all visible cancer. About 82 patients will be randomly assigned…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC